Clinical Trial Update: Diabetes Virus Detection Project, Intervention With GAD-alum [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating GAD-alum for Type 1 diabetes mellitus has been terminated. The study, sponsored by Oslo University Hospital, also involves Enteroviru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Enterovirus Infections
• Type 1 Diabetes Mellitus

Drugs mentioned

• GAD-alum (glutamic acid decarboxylase (GAD65) formulated with aluminum hydroxide)

Snippet

Sponsor: Oslo University Hospital | Conditions: Diabetes, Type I, Enterovirus Infections | Phase 2 | Status: TERMINATED